Order Article Reprints

Darwish SS, Chen P-J, Hamed MM, Wagdy RA, Chen S-H, Abadi AH, Abdel-Halim M, Hwang T-L, Engel M. Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors. Pharmaceuticals. 2022; 15(7):778. https://doi.org/10.3390/ph15070778

Darwish, Sarah S., Po-Jen Chen, Mostafa M. Hamed, Reem A. Wagdy, Shun-Hua Chen, Ashraf H. Abadi, Mohammad Abdel-Halim, Tsong-Long Hwang, and Matthias Engel. 2022. "Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors" Pharmaceuticals 15, no. 7: 778. https://doi.org/10.3390/ph15070778

Darwish, S. S., Chen, P. -J., Hamed, M. M., Wagdy, R. A., Chen, S. -H., Abadi, A. H., Abdel-Halim, M., Hwang, T. -L., & Engel, M. (2022). Development of (4-Phenylamino)quinazoline Alkylthiourea Derivatives as Novel NF-κB Inhibitors. Pharmaceuticals, 15(7), 778. https://doi.org/10.3390/ph15070778